MedTrace Logo

the Effect of Carbetocin in Decreasing Intraoperative Blood Loss in Abdominal Myomectomy

NCT04083625 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 138

Last updated 2020-04-08

No results posted yet for this study

Summary

To investigate the effectiveness of carbetocin on reducing intraoperative blood loss during abdominal myomectomy

Conditions

  • Abdominal Myomectomy

Interventions

DRUG

carbetocin 100 mcg

a 10 cm syringe containing 100 mcg carbetocin just before skin incision of myomectomy.

DRUG

placebo

a 10 cm syringe normal saline IV given just before skin incision of myomectomy.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • AHMED SAMY · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-10
Primary Completion
2020-02-10
Completion
2020-02-20

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04083625 on ClinicalTrials.gov